Bioplastics Global Market Report 2022: Encouraging Government Legislation Fueling Adoption & Growth

2022-10-16 07:26:01 By : Mr. Barton Zhang

Dublin, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The "Bioplastics Market, Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering. Global Bioplastics Market is expected to reach US$ 9.9 Billion by 2027. Bioplastics have been regarded as a potential solution to address environmental and economic challenges in recent years. Bioplastics is a sustainable material from renewable feedstock and an alternative to petroleum-based plastics, reducing 30-70% of carbon dioxide emissions.

It represents an approximately 42% reduction of carbon footprints. Remarkably, bioplastics represent the fastest growing product line for bio-based products. Moreover, the adoption of bioplastics has increased tremendously across various applications, owing to the advanced technical properties and functionalities. Besides, the demand for bioplastics has gained incredible traction across multiple plastic applications due to the encouraging legislation implemented by various governments around the globe. Worldwide Bioplastics Industry will expand with a CAGR of 6.7% during 2021-2027 Since the past decade, the demand for bioplastics has increased due to growing awareness concerning environmental conservation, bio-based or natural resources for manufacturing materials, and various regulations across countries for effective use of natural resources and waste management. Further, as an alternative to conventional fossil-based plastics, the use of biomass based-plastics is being promoted for applications wherein the former was generally utilized. Further, due to numerous agencies' stringent laws and legislation on the usage of non-renewable, single-use plastics, industries have deviated their focus on developing and utilizing bioplastics for innumerable purposes. Bioplastics Packaging - An Integral Part of the Global Bioplastics Market's Application: With the evolution of time, bioplastics have found their application in packaging, agriculture, consumer goods, textile, automotive and transportation, building and construction. Besides, bioplastic packaging has been of fundamental significance over the years. Recently, bioplastic packaging has become an integral part of the global bioplastic market's application. Bioplastics apply in various sectors, including fibers, medical, packaging, and agriculture. The rising consumer awareness towards bioplastic packaging has led to the tremendous growth of the overall market. In addition, eco-friendly initiatives by corporates and abundant availability of raw materials for manufacturing bioplastics are prominent factors driving growth for the global bioplastics market. PLA to Pace Biodegradables: Biodegradable plastics account for their majority application in the world bioplastics market. Excellent growth is forecast for the leading biodegradable plastics such as polylactic acid (PLA), which will pace its demand through 2021. As per the analysis, rapid growth for PLA is expected to benefit from advancements in compounding polymerization technology and it's relatively low cost compared to other bioplastics. Similarly, the fastest gains for biodegradable plastics will also be seen for polyhydroxyalkanoate (PHA) resins, which are just entering the commercial market. Non-Biodegradable Polytrimethylene Terephthalate (PTT) to Lead Gains: Despite the solid advances for biodegradables, non-biodegradable Polytrimethylene Terephthalate (PTT) will be the primary driver of bioplastics demand through 2021 and beyond. Majorly, gains will be fuelled by the industrial and residential carpet market. Polytrimethylene Terephthalate is used in the textile industry as it can be spun both in yarn and fibers. Also, PTT can be used in textiles and apparel, non-woven films, engineering thermoplastics, and monofilaments. Besides, PTT is used in carpets for the automotive market. Hence, this material finds apparel, home furnishing, and automobile upholstery applications. Remarkably, PTT composites and bio-composites can be significant opportunities for the market. Asia-Pacific Is Well Positioned to Become A Global Bioplastics Hub: Asia-Pacific is well-positioned to become a global bioplastics hub. The Asia-Pacific is a leading producer of the raw materials required for bioplastic synthesis and is well equipped with progressive technology and technical expertise through all phases of the supply chain. Consumers in the market have access to the industry, and a solid governmental supporting policy has been implemented to fuel growth in the bioplastic sector. Hence, all of these factors highlight Asia-Pacific's readiness to emerge as a global bioplastic hub. Material Type - Global Bioplastics has been covered from 2 viewpoints: 1. Biodegradable 2. Non-Biodegradable Biodegradable - Global Bioplastics has been covered from 6 viewpoints: 1. Polybutylene adipate Terephthalate (PBAT) 2. Polybutylene Succinate (PBS) 3. Polylactic Acid (PLA) 4. Polyhydroxyalkanoate (PHA) 5. Starch Blends 6. Others Non-Biodegradable - Global Bioplastics has been covered from 6 viewpoints: 1. Polyethylene (PE) 2. Polyethylene terephthalate (PET) 3. Polyamide (PA) 4. Polypropylene (PP) 5. Polytrimethylene terephthalate) ( PTT) 6. Others Applications - Global Bioplastics Market has been covered from 7 viewpoints: 1. Packaging 2. Agriculture 3. Consumer Goods 4. Textile 5. Automotive and Transportation Region - Global Bioplastics Market has been covered from 4 viewpoints: 1. North America 2. Europe 3. Asia Pacific 4. Rest of the World

Key Topics Covered: 1. Introduction 2. Research & Methodology 3. Executive Summary 4. Market Dynamics 5. Global Bioplastics Analysis 6. Market Share - Global Bioplastics Analysis 7. Volume Share - Global Bioplastics Analysis 8. Material Type - Global Bioplastics Market 9. Applications - Global Bioplastics Market 10. Regions - Global Bioplastics Market 11. Porters Five Forces 12. Company Analysis Companies Mentioned

Mitsubishi Chemical Holding Corporation (Japan)

For more information about this report visit https://www.researchandmarkets.com/r/577ow9

The U.S. stock market took an unusual swing after Thursday’s inflation report. “Shortly after the open, the S&P 500 index had dropped nearly 4% from its pre-market highs before staging an epic rally of over 5%,” Bespoke Investment Group said in a note Friday. “Even in this ‘all or nothing’ type of market environment, reversals of that magnitude are rare.”

It's never a dull time analyzing Tesla's (NASDAQ: TSLA) stock. The innovative electric-car company always seems to have something interesting going on. In this video, we take a beginner-friendly walk-through of Tesla's second-quarter earnings transcript.

Investors seemingly can’t stop trying to pick a stock market bottom, no matter how bad the news—and it continues to backfire. Consider: This past Thursday, September’s consumer inflation report came in much hotter than expected, with the core CPI hitting a 40-year high. The initial response was exactly what you’d expect—the traded down as much as 2.4%—but then it started rallying…and rallying.

The economist warned in 2006 that the U.S. housing bust would cause a financial crisis. Now he has a new economic doomsday prediction, and it isn't pretty.

These diversified natural-resource giants have solid balance sheets, earnings, and dividends. All that they need is a rebound in commodity prices.

Making investments pay out for the long term is the true challenge in today’s market environment. The series of headwinds piling up – from persistently high inflation to rising interest rates to slowing demand to bureaucratic bloat – are rising to hurricane force, and renewing investors’ attention to defensive stocks. It’s only logical. The classic defensive stock, the dividend payer, ensures an income stream no matter how the markets move, and if the yield is high enough, these stocks can also

(Bloomberg) -- Federal Reserve Bank of St. Louis President James Bullard left open the possibility that the central bank would raise interest rates by 75 basis points at each of its next two meetings in November and December, while saying it was too soon to make that call.Most Read from BloombergRolex Prices to Drop Further as Supply Surges: Morgan StanleyDiesel Hits Chaos Mode in Fresh Blow for Global EconomySecret Service Minimized Threats Before Jan. 6, Documents ShowPutin Tried for Years to

This week’s worse-than-expected inflation report led to turmoil in more than one market, but you only read about one of them. What got far less attention was the flurry of excitement that the inflation report caused in the normally-staid I-bond market.

Things have been even worse for the technology stock-driven Nasdaq Composite (NASDAQINDEX: ^IXIC). Historically, every double-digit percentage decline in the major U.S. stock indexes, including the Nasdaq, has eventually been placed in the rearview mirror by a bull market rally. This makes every bear market a surefire buying opportunity for patient investors.

This hasn't been a great year for chip stocks, but Advanced Micro Devices' positive, long-term trajectory is undeniable.

Investors were surprised by the big rally in the stock market on Thursday, but Friday brought another dose of reality and disappointment. After having posted monumental gains despite high readings on inflation, the Nasdaq Composite (NASDAQINDEX: ^IXIC) closed at its worst level of the year, and the S&P 500 (SNPINDEX: ^GSPC) and Dow Jones Industrial Average (DJINDICES: ^DJI) gave up most of their advances from earlier in the week. One of the biggest stock stories of the past several years has been Tesla (NASDAQ: TSLA).

Future Fund Active ETF co-founder Gary Black recommends to Tesla's board how it should spend some of the electric-vehicle company's cash.

With this in mind, we asked three Motley Fool contributors to pick beaten-down stocks to buy and hold. Here's why they chose Abbott Laboratories (NYSE: ABT), Moderna (NASDAQ: MRNA), and Pfizer (NYSE: PFE). Keith Speights (Abbott Laboratories): Shares of Abbott Laboratories have fallen close to 30% year to date.

In the midst of a bear market, with rising interest rates and the threat of a prolonged recession in the air, real estate investment trust (REIT) stocks have endured tremendous price declines. Given this, it isn’t easy to find REITs that could see dividend increases soon. Two questions come to mind. Why would a company raise its dividend when the yield is already increasing with each drop in price? And how do you find REITs with the dividend well-covered by funds from operations (FFO) and with s

The iconic investor's approach could work for anyone hoping to retire with significant dividend income.

In this article, we will take a look at 11 of the best financial services stocks to buy now. If you want to see some more of the 11 best financial services stocks to buy, go directly to 5 Best Financial Services Stocks to Buy Now. Financial services stocks provide many different services to their […]

(Bloomberg) -- In most market environments, a company with one of the lowest valuations in the Nasdaq 100 Index, a solid balance sheet and sales growth averaging 34% a year would be an obvious buy. In the case of Meta Platforms Inc., it’s not so obvious. Since Mark Zuckerberg’s announcement a year ago of a name change and strategy overhaul for the owner of Facebook, the stock has wiped out more than half the gain it had seen since its initial public offering a decade ago. That’s cost Meta $600 b

The Senior Citizen’s League says there ‘may be no COLA payable in 2024.'

Stocks have been under tremendous pressure this year, driven down by concerns that raising interest rates to combat inflation will push the economy into a recession. A deep downturn would affect how much money companies in economically sensitive sectors earn, limiting their ability to make new investments and return cash to shareholders. Three highly resilient companies are Enbridge (NYSE: ENB), Realty Income (NYSE: O), and WM (NYSE: WM).

Markets are struggling to extend the previous session’s impressive rebound. There may be a number of reasons why a worse-than-expected inflation report was eventually shrugged off with such vigor on Thursday. Oversold conditions in stocks: at the low early on Thursday the S&P 500 was down nearly 27% for the year, and buyers pounced near the nice round figure of 3,500.